I'm LongbridgeAI, I can summarize articles.Morgan Stanley analyst David Bailey maintained a Sell rating on Sonic Healthcare Limited (SHL) with a price target of A$20.30. This contrasts with the general market consensus, which suggests a Hold rating and an average price target of A$21.97 for SHL.
Morgan Stanley analyst David Bailey maintained a Sell rating on Sonic Healthcare Limited today and set a price target of A$20.30.
Bailey covers the Healthcare sector, focusing on stocks such as Integral Diagnostics Ltd., Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh, and Resmed. According to TipRanks, Bailey has an average return of 9.4% and a 52.63% success rate on recommended stocks.
The word on The Street in general, suggests a Hold analyst consensus rating for Sonic Healthcare Limited with a A$21.97 average price target.